Misplaced Pages

#497502

59-445: 7276 22139 ENSG00000118271 ENSMUSG00000061808 P02766 P07309 NM_000371 NM_013697 NP_000362 NP_038725 Transthyretin ( TTR or TBPA ) is a transport protein in the plasma and cerebrospinal fluid that transports the thyroid hormone thyroxine (T 4 ) and retinol to the liver. This is how transthyretin gained its name: trans ports thy roxine and retin ol . The liver secretes TTR into

118-435: A frameshift mutation ). Point mutations that occur in non-coding sequences are most often without consequences, although there are exceptions. If the mutated base pair is in the promoter sequence of a gene, then the expression of the gene may change. Also, if the mutation occurs in the splicing site of an intron , then this may interfere with correct splicing of the transcribed pre-mRNA . By altering just one amino acid,

177-402: A change to one amino acid in the protein is not detrimental to the organism as a whole. Most proteins can withstand one or two point mutations before their function changes. Non-conservative mutations result in an amino acid change that has different properties than the wild type . The protein may lose its function, which can result in a disease in the organism. For example, sickle-cell disease

236-488: A codon coding for the amino acid glycine may be changed to a stop codon, causing the proteins that should have been produced to be deformed and unable to complete their intended tasks. Because the mutations can affect the DNA and thus the chromatin , it can prohibit mitosis from occurring due to the lack of a complete chromosome. Problems can also arise during the processes of transcription and replication of DNA. These all prohibit

295-496: A crude form of gene therapy. Because TTR is primarily produced in the liver, replacement of a liver containing a mutant TTR gene with a normal gene is able to reduce the mutant TTR levels in the body to < 5% of pretransplant levels. Certain mutations, however, cause CNS amyloidosis, and due to their production by the choroid plexus, the CNS TTR amyloid diseases do not respond to gene therapy mediated by liver transplantation. In 2011,

354-531: A fatty substance called GM2 ganglioside in nerve cells. Mutations in the HEXA gene disrupt the activity of beta-hexosaminidase A, preventing the breakdown of the fatty substances. As a result, the fatty substances accumulate to deadly levels in the brain and spinal cord. The buildup of GM2 ganglioside causes progressive damage to the nerve cells. This is the cause of the signs and symptoms of Tay-Sachs disease. In molecular biology , repeat-induced point mutation or RIP

413-558: A lower thyroxine transport in brains of patients with schizophrenia. Transthyretin is known to contain a Gla domain , and thus be dependent for production on post-translational modification requiring vitamin K , but the potential link between vitamin k status and thyroid function has not been explored. Because transthyretin is made in part by the choroid plexus , it can be used as an immunohistochemical marker for choroid plexus papillomas as well as carcinomas. As of March 2015, there are two ongoing clinical trials undergoing recruitment in

472-420: A non-conservative (missense) mutation. Silent mutations code for the same amino acid (a " synonymous substitution "). A silent mutation does not affect the functioning of the protein . A single nucleotide can change, but the new codon specifies the same amino acid, resulting in an unmutated protein. This type of change is called synonymous change since the old and new codon code for the same amino acid. This

531-415: A protein depending on where the mutation occurs in the amino acid sequence of the protein. If the mutation occurs in the region of the gene that is responsible for coding for the protein, the amino acid may be altered. This slight change in the sequence of amino acids can cause a change in the function, activation of the protein meaning how it binds with a given enzyme, where the protein will be located within

590-436: A purine with a pyrimidine or vice versa. There is a systematic difference in mutation rates for transitions (Alpha) and transversions (Beta). Transition mutations are about ten times more common than transversions. Nonsense mutations include stop-gain and start-loss. Stop-gain is a mutation that results in a premature termination codon ( a stop was gained ), which signals the end of translation. This interruption causes

649-420: A transcript's AUG start codon, resulting in the reduction or elimination of protein production. Missense mutations code for a different amino acid. A missense mutation changes a codon so that a different protein is created, a non-synonymous change. Conservative mutations result in an amino acid change. However, the properties of the amino acid remain the same (e.g., hydrophobic, hydrophilic, etc.). At times,

SECTION 10

#1732844343498

708-504: A variety of effects on the downstream protein product—consequences that are moderately predictable based upon the specifics of the mutation. These consequences can range from no effect (e.g. synonymous mutations ) to deleterious effects (e.g. frameshift mutations ), with regard to protein production, composition, and function. Point mutations usually take place during DNA replication . DNA replication occurs when one double-stranded DNA molecule creates two single strands of DNA, each of which

767-435: Is a membrane protein that acts as such a carrier. A vesicular transport protein is a transmembrane or membrane associated protein . It regulates or facilitates the movement by vesicles of the contents of the cell. Point mutation A point mutation is a genetic mutation where a single nucleotide base is changed, inserted or deleted from a DNA or RNA sequence of an organism's genome. Point mutations have

826-446: Is a chart depicting the first thirteen amino acids in the normal and abnormal sickle cell polypeptide chain. The cause of Tay–Sachs disease is a genetic defect that is passed from parent to child. This genetic defect is located in the HEXA gene, which is found on chromosome 15. The HEXA gene makes part of an enzyme called beta-hexosaminidase A, which plays a critical role in the nervous system. This enzyme helps break down

885-536: Is a process by which DNA accumulates G : C to A : T transition mutations. Genomic evidence indicates that RIP occurs or has occurred in a variety of fungi while experimental evidence indicates that RIP is active in Neurospora crassa , Podospora anserina , Magnaporthe grisea , Leptosphaeria maculans , Gibberella zeae and Nectria haematococca . In Neurospora crassa , sequences mutated by RIP are often methylated de novo . RIP occurs during

944-507: Is a template for the creation of the complementary strand. A single point mutation can change the whole DNA sequence. Changing one purine or pyrimidine may change the amino acid that the nucleotides code for. Point mutations may arise from spontaneous mutations that occur during DNA replication . The rate of mutation may be increased by mutagens . Mutagens can be physical, such as radiation from UV rays , X-rays or extreme heat, or chemical (molecules that misplace base pairs or disrupt

1003-405: Is believed to have evolved as a defense mechanism against transposable elements , which resemble parasites by invading and multiplying within the genome. RIP creates multiple missense and nonsense mutations in the coding sequence. This hypermutation of G-C to A-T in repetitive sequences eliminates functional gene products of the sequence (if there were any to begin with). In addition, many of

1062-590: Is caused by a single point mutation (a missense mutation) in the beta- hemoglobin gene that converts a GAG codon into GUG, which encodes the amino acid valine rather than glutamic acid . The protein may also exhibit a "gain of function" or become activated, such is the case with the mutation changing a valine to glutamic acid in the BRAF gene; this leads to an activation of the RAF protein which causes unlimited proliferative signalling in cancer cells. These are both examples of

1121-596: Is caused by point mutations in the Neurofibromin 1 or Neurofibromin 2 gene. Sickle-cell anemia is caused by a point mutation in the β-globin chain of hemoglobin, causing the hydrophilic amino acid glutamic acid to be replaced with the hydrophobic amino acid valine at the sixth position. The β-globin gene is found on the short arm of chromosome 11. The association of two wild-type α-globin subunits with two mutant β-globin subunits forms hemoglobin S (HbS). Under low-oxygen conditions (being at high altitude, for example),

1180-537: Is created from the genetic information on the HBB, or "hemoglobin, beta" gene found on chromosome 11p15.5. A single point mutation in this polypeptide chain, which is 147 amino acids long, results in the disease known as Sickle Cell Anemia. Sickle-cell anemia is an autosomal recessive disorder that affects 1 in 500 African Americans, and is one of the most common blood disorders in the United States. The single replacement of

1239-557: Is encoded by the TTR gene located on the 18th chromosome. It functions in concert with two other thyroid hormone-binding proteins in the serum: In cerebrospinal fluid TTR is the primary carrier of T 4 . TTR also acts as a carrier of retinol (vitamin A) through its association with retinol-binding protein (RBP) in the blood and the CSF. Less than 1% of TTR's T 4 binding sites are occupied in blood, which

SECTION 20

#1732844343498

1298-479: Is estimated to affect over 25% of the population over age 80. Severity of disease varies greatly by mutation, with some mutations causing disease in the first or second decade of life, and others being more benign. Deposition of TTR amyloid is generally observed extracellularly, although TTR deposits are also clearly observed within the cardiomyocytes of the heart. Treatment of familial (hereditary) TTR amyloid disease has historically relied on liver transplantation as

1357-512: Is known to be rate-limiting for amyloid fibril formation. However, the monomer also must partially denature in order for TTR to be mis-assembly competent, leading to a variety of aggregate structures, including amyloid fibrils. At least 114 disease-causing mutations in this gene have been discovered. While wild type TTR can dissociate, misfold, and aggregate, leading to SSA (senile systemic amyloidosis), point mutations within TTR are known to destabilize

1416-405: Is possible because 64 codons specify only 20 amino acids. Different codons can lead to differential protein expression levels, however. Sometimes the term point mutation is used to describe insertions or deletions of a single base pair (which has more of an adverse effect on the synthesized protein due to the nucleotides' still being read in triplets, but in different frames: a mutation called

1475-409: Is synthesized in the liver , choroid plexus and retinal pigment epithelium for secretion into the bloodstream, cerebrospinal fluid and the eye, respectively. Each monomer is a 127-residue polypeptide rich in beta sheet structure. Association of two monomers via their edge beta-strands forms an extended beta sandwich. Further association of two of these dimers in a face-to-face fashion produces

1534-440: Is taken advantage of below to prevent TTRs dissociation, misfolding and aggregation which leads to the degeneration of post-mitotic tissue. Numerous other small molecules are known to bind in the thyroxine binding sites, including many natural products (such as resveratrol ), drugs ( tafamidis , diflunisal , and flufenamic acid ), and toxicants ( PCB ). TTR is a 55kDa homotetramer with a dimer of dimers quaternary structure that

1593-511: Is the only known protein essential for RIP. It is a DNA methyltransferease-like protein, that when mutated or knocked out results in loss of RIP. Deletion of the rid homolog in Aspergillus nidulans , dmtA , results in loss of fertility while deletion of the rid homolog in Ascobolus immersens , masc1 , results in fertility defects and loss of methylation induced premeiotically (MIP) . RIP

1652-555: The European Medicines Agency approved tafamidis (Vyndaqel) for the amelioration of FAP. Tafamidis kinetically stabilizes the TTR tetramer, preventing tetramer dissociation required for TTR amyloidogenesis and degradation of the autonomic nervous system and/or the peripheral nervous system and/or the heart. TTR is also thought to have beneficial side effects, by binding to the infamous beta-amyloid protein, thereby preventing beta-amyloid's natural tendency to accumulate into

1711-503: The C-bearing nucleotides become methylated , thus decreasing transcription. Because RIP is so efficient at detecting and mutating repeats, fungal biologists often use it as a tool for mutagenesis . A second copy of a single-copy gene is first transformed into the genome . The fungus must then mate and go through its sexual cycle to activate the RIP machinery. Many different mutations within

1770-488: The United States and worldwide to evaluate potential treatments for TTR amyloidosis. Transthyretin has been shown to interact with perlecan . Transport protein A transport protein (variously referred to as a transmembrane pump , transporter , escort protein , acid transport protein , cation transport protein , or anion transport protein ) is a protein that serves the function of moving other materials within an organism . Transport proteins are vital to

1829-463: The absence of a polar amino acid at position six of the β-globin chain promotes the non-covalent polymerisation (aggregation) of hemoglobin, which distorts red blood cells into a sickle shape and decreases their elasticity. Hemoglobin is a protein found in red blood cells, and is responsible for the transportation of oxygen through the body. There are two subunits that make up the hemoglobin protein: beta-globins and alpha-globins . Beta-hemoglobin

Transthyretin - Misplaced Pages Continue

1888-407: The blood, and the choroid plexus secretes TTR into the cerebrospinal fluid . TTR was originally called prealbumin (or thyroxine-binding prealbumin) because it migrated faster than albumin on electrophoresis gels. Prealbumin was felt to be a misleading name, it is not a synthetic precursor of albumin. The alternative name TTR was proposed by DeWitt Goodman in 1981. Transthyretin protein

1947-400: The cell from reproduction and thus lead to the death of the cell. Long-term effects can be a permanent changing of a chromosome, which can lead to a mutation. These mutations can be either beneficial or detrimental. Cancer is an example of how they can be detrimental. Other effects of point mutations, or single nucleotide polymorphisms in DNA, depend on the location of the mutation within

2006-427: The cell, or the amount of free energy stored within the protein. If the mutation occurs in the region of the gene where transcriptional machinery binds to the protein, the mutation can affect the way in which transcription factors bind to the protein. The mechanisms of transcription bind to a protein through recognition of short nucleotide sequences. A mutation in this region may alter these sequences and, thus, change

2065-408: The degeneration of post-mitotic tissue causing FAP and likely FAC and SSA. Evidence points to the oligomers generated in the process of amyloidogenicity leading to the observed proteotoxicity . Transthyretin level in cerebrospinal fluid has also been found to be lower in patients with some neurobiological disorders such as schizophrenia . The reduced level of transthyretin in the CSF may indicate

2124-589: The duplicated gene are obtained from even a single fertilization event so that inactivated alleles, usually due to nonsense mutations , as well as alleles containing missense mutations can be obtained. The cellular reproduction process of meiosis was discovered by Oscar Hertwig in 1876. Mitosis was discovered several years later in 1882 by Walther Flemming . Hertwig studied sea urchins, and noticed that each egg contained one nucleus prior to fertilization and two nuclei after. This discovery proved that one spermatozoon could fertilize an egg, and therefore proved

2183-409: The entire peptide may change, thereby changing the entire protein. The new protein is called a protein variant . If the original protein functions in cellular reproduction then this single point mutation can change the entire process of cellular reproduction for this organism. Point germline mutations can lead to beneficial as well as harmful traits or diseases. This leads to adaptations based on

2242-469: The environment where the organism lives. An advantageous mutation can create an advantage for that organism and lead to the trait's being passed down from generation to generation, improving and benefiting the entire population. The scientific theory of evolution is greatly dependent on point mutations in cells . The theory explains the diversity and history of living organisms on Earth. In relation to point mutations, it states that beneficial mutations allow

2301-422: The evolutionary conservation assuming that changes at conserved positions tend to be more deleterious. While majority of methods provide a binary classification of effects of mutations into damaging and benign, a new level of annotation is needed to offer an explanation of why and how these mutations damage proteins. Moreover, if the mutation occurs in the region of the gene where transcriptional machinery binds to

2360-551: The gene. For example, if the mutation occurs in the region of the gene responsible for coding, the amino acid sequence of the encoded protein may be altered, causing a change in the function, protein localization, stability of the protein or protein complex. Many methods have been proposed to predict the effects of missense mutations on proteins. Machine learning algorithms train their models to distinguish known disease-associated from neutral mutations whereas other methods do not explicitly train their models but almost all methods exploit

2419-436: The growth and life of all living things. There are several different kinds of transport proteins. Carrier proteins are proteins involved in the movement of ions , small molecules , or macromolecules , such as another protein, across a biological membrane . Carrier proteins are integral membrane proteins; that is, they exist within and span the membrane across which they transport substances. The proteins may assist in

Transthyretin - Misplaced Pages Continue

2478-574: The helical shape of DNA). Mutagens associated with cancers are often studied to learn about cancer and its prevention. There are multiple ways for point mutations to occur. First, ultraviolet (UV) light and higher-frequency light have ionizing capability, which in turn can affect DNA. Reactive oxygen molecules with free radicals, which are a byproduct of cellular metabolism, can also be very harmful to DNA. These reactants can lead to both single-stranded and double-stranded DNA breaks. Third, bonds in DNA eventually degrade, which creates another problem to keep

2537-558: The homotetrameric structure and creates the two thyroxine binding sites per tetramer. This dimer-dimer interface, comprising the two T 4 binding sites, is the weaker dimer-dimer interface and is the one that comes apart first in the process of tetramer dissociation. TTR misfolding and aggregation is known to be associated with amyloid diseases including wild-type transthyretin amyloidosis , hereditary transthyretin amyloidosis , familial amyloid polyneuropathy (FAP), and familial amyloid cardiomyopathy (FAC). TTR tetramer dissociation

2596-425: The integrity of DNA to a high standard. There can also be replication errors that lead to substitution, insertion, or deletion mutations. In 1959 Ernst Freese coined the terms "transitions" or "transversions" to categorize different types of point mutations. Transitions are replacement of a purine base with another purine or replacement of a pyrimidine with another pyrimidine. Transversions are replacement of

2655-540: The movement of substances by facilitated diffusion (i.e., passive transport) or active transport . These mechanisms of movement are known as carrier-mediated transport . Each carrier protein is designed to recognize only one substance or one group of very similar substances. Research suggests that potassium, calcium and sodium channels can function as oxygen sensors in mammals and plants, and has correlated defects in specific carrier proteins with specific diseases. A membrane transport protein (or simply transporter )

2714-432: The organism to thrive and reproduce, thereby passing its positively affected mutated genes on to the next generation. On the other hand, harmful mutations cause the organism to die or be less likely to reproduce in a phenomenon known as natural selection . There are different short-term and long-term effects that can arise from mutations. Smaller ones would be a halting of the cell cycle at numerous points. This means that

2773-410: The original start site, in-frame within the processed transcript and downstream to a ribosomal binding site, it can be used to initiate translation. The likely effect is additional amino acids added to the amino terminus of the original protein. Frame-shift mutations are also possible in start-gain mutations, but typically do not affect translation of the original protein. Start-loss is a point mutation in

2832-508: The phytopathogenic fungus L. maculans , RIP mutations are found in single copy regions, adjacent to the repeated elements. These regions are either non-coding regions or genes encoding small secreted proteins including avirulence genes. The degree of RIP within these single copy regions was proportional to their proximity to repetitive elements. Rep and Kistler have speculated that the presence of highly repetitive regions containing transposons, may promote mutation of resident effector genes. So

2891-436: The plaques associated with the early stages of Alzheimer's disease . Preventing plaque formation is thought to enable a cell to rid itself of this otherwise toxic protein form and, thus, help prevent and maybe even treat the disease. There is now strong genetic and pharmacologic data (see European Medicines Agency website for the tafamidis clinical trial results) indicating that the process of amyloid fibril formation leads to

2950-465: The presence of effector genes within such regions is suggested to promote their adaptation and diversification when exposed to strong selection pressure. As RIP mutation is traditionally observed to be restricted to repetitive regions and not single copy regions, Fudal et al. suggested that leakage of RIP mutation might occur within a relatively short distance of a RIP-affected repeat. Indeed, this has been reported in N. crassa whereby leakage of RIP

3009-496: The process of meiosis. Hermann Fol continued Hertwig's research by testing the effects of injecting several spermatozoa into an egg, and found that the process did not work with more than one spermatozoon. Flemming began his research of cell division starting in 1868. The study of cells was an increasingly popular topic in this time period. By 1873, Schneider had already begun to describe the steps of cell division. Flemming furthered this description in 1874 and 1875 as he explained

SECTION 50

#1732844343498

3068-406: The protein to be abnormally shortened. The number of amino acids lost mediates the impact on the protein's functionality and whether it will function whatsoever. Stop-loss is a mutation in the original termination codon ( a stop was lost ), resulting in abnormal extension of a protein's carboxyl terminus. Start-gain creates an AUG start codon upstream of the original start site. If the new AUG is near

3127-408: The protein, the mutation can affect the binding of the transcription factors because the short nucleotide sequences recognized by the transcription factors will be altered. Mutations in this region can affect rate of efficiency of gene transcription, which in turn can alter levels of mRNA and, thus, protein levels in general. Point mutations can have several effects on the behavior and reproduction of

3186-542: The sexual stage in haploid nuclei after fertilization but prior to meiotic DNA replication . In Neurospora crassa , repeat sequences of at least 400 base pairs in length are vulnerable to RIP. Repeats with as low as 80% nucleotide identity may also be subject to RIP. Though the exact mechanism of repeat recognition and mutagenesis are poorly understood, RIP results in repeated sequences undergoing multiple transition mutations . The RIP mutations do not seem to be limited to repeated sequences. Indeed, for example, in

3245-457: The sixth amino acid in the beta-globin, glutamic acid, with valine results in deformed red blood cells. These sickle-shaped cells cannot carry nearly as much oxygen as normal red blood cells and they get caught more easily in the capillaries, cutting off blood supply to vital organs. The single nucleotide change in the beta-globin means that even the smallest of exertions on the part of the carrier results in severe pain and even heart attack. Below

3304-484: The steps in more detail. He also argued with Schneider's findings that the nucleus separated into rod-like structures by suggesting that the nucleus actually separated into threads that in turn separated. Flemming concluded that cells replicate through cell division, to be more specific mitosis. Matthew Meselson and Franklin Stahl are credited with the discovery of DNA replication . Watson and Crick acknowledged that

3363-472: The tetramer composed of mutant and wild-type TTR subunits, facilitating more facile dissociation and/or misfolding and amyloidogenesis. A replacement of valine by methionine at position 30 (TTR V30M) is the mutation most commonly associated with FAP. A position 122 replacement of valine by isoleucine (TTR V122I) is carried by 3.9% of the African-American population, and is the most common cause of FAC. SSA

3422-585: The way the transcription factors bind to the protein. Mutations in this region can affect the efficiency of gene transcription, which controls both the levels of mRNA and overall protein levels. Point mutations in multiple tumor suppressor proteins cause cancer . For instance, point mutations in Adenomatous Polyposis Coli promote tumorigenesis. A novel assay, Fast parallel proteolysis (FASTpp) , might help swift screening of specific stability defects in individual cancer patients. Neurofibromatosis

3481-406: Was detected in single copy sequences at least 930 bp from the boundary of neighbouring duplicated sequences. To elucidate the mechanism of detection of repeated sequences leading to RIP may allow to understand how the flanking sequences may also be affected. RIP causes G : C to A : T transition mutations within repeats, however, the mechanism that detects the repeated sequences is unknown. RID

#497502